Showing results (11-20 of 103) with videos related to
Sort By:
Pageof 11
Pathology, Research and Practice|June 26, 2007
Inhalation of inorganic particles as a risk factor for idiopathic pulmonary fibrosis--elemental microanalysis of pulmonary lymph nodes obtained at autopsy casesHideya Kitamura, Shizuko Ichinose, Takumi Hosoya, et al.BMC Pulmonary Medicine|March 5, 2016
Administration of nintedanib after discontinuation for acute exacerbation of idiopathic pulmonary fibrosis: a case reportSatoshi Ikeda, Akimasa Sekine, Tomohisa Baba, et al.Acta Radiologica (Stockholm, Sweden : 1987)|November 12, 2024
Interstitial lung disease associated with anti-aminoacyl-tRNA synthetase syndrome: quantitative evaluation of CT after initial treatment and long-term follow-upRyo Aoki, Tae Iwasawa, Daisuke Utsunomiya, et al.Respiratory Medicine|November 10, 2025
Upper-lobe subpleural irregularity predicts progression and mortality in idiopathic pulmonary fibrosisTsuneyuki Oda, Hideya Kitamura, Tomohisa Baba, et al.Chemotherapy|May 5, 2017
Ten-Year Trends and Clinical Relevance of the Antimicrobial Resistance Genotype in Respiratory Isolates of Streptococcus pneumoniaeEri Hagiwara, Tomohisa Baba, Takeshi Shinohara, et al.Kekkaku : [Tuberculosis]|June 10, 2014
[Clinical features of pulmonary Mycobacterium avium complex disease diagnosed through gastric aspirate culture]Akiyuki Takasa, Eri Hagiwara, Akimasa Sekine, et al.Journal of Cardiology Cases|June 26, 2023
Severe multivessel coronary vasospasm in a patient with coronavirus disease 2019Mai Azuma, Shingo Kato, Kota Murohashi, et al.Kekkaku : [Tuberculosis]|June 30, 2017
[[COMPLIANCE RATE OF STANDARD TREATMENT REGIMEN AND OPTIMAL DOSE OF ANTI-TUBERCULOSIS DRUGS IN LATE ELDERLY PATIENTS WITH PULMONARY TUBERCULOSIS].]Haruka Chino, Eri Hagiwara, Akimasa Sekine, et al.Respiratory Investigation|July 19, 2024
Nonfibrotic (cellular) hypersensitivity pneumonitis with and without slight lung distortionRyo Okuda, Tamiko Takemura, Toshihiro Misumi, et al.Respiratory Investigation|August 10, 2021
Impact of interstitial pneumonia complications on palliative medication for terminal lung cancer: A single-center retrospective studyHiroko Okabayashi, Hideya Kitamura, Satoshi Ikeda, et al.Pageof 11